![Medically Necessary artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts124/v4/87/d3/de/87d3defc-bd88-fcba-7e03-6ffcf08ff168/mza_9329751908922792886.jpg/100x100bb.jpg)
The case for repatriating the U.S. drug supply
Medically Necessary
English - September 23, 2021 20:10 - 25 minutesBusiness News News Health & Fitness Medicine freightwaves medically necessary Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Shortages of many generic drugs have plagued the U.S. health system for decades. The leading cause of drug shortages is quality issues at manufacturing plants, which are mostly located overseas. Some experts argue that bringing pharmaceutical production back to the U.S. will help companies and regulators better monitor manufacturing and avoid issues.
Follow Medically Necessary on Apple Podcasts
Follow Medically Necessary on Spotify
More FreightWaves Podcasts
Learn more about your ad choices. Visit megaphone.fm/adchoices
Shortages of many generic drugs have plagued the U.S. health system for decades. The leading cause of drug shortages is quality issues at manufacturing plants, which are mostly located overseas. Some experts argue that bringing pharmaceutical production back to the U.S. will help companies and regulators better monitor manufacturing and avoid issues.
Follow Medically Necessary on Apple Podcasts
Follow Medically Necessary on Spotify
Learn more about your ad choices. Visit megaphone.fm/adchoices